Primary progressive aphasia remains a diagnostic challenge despite (or even because of) the increasing availability of ancillary tests and biomarkers. We present a 67-year-old man with apparently sporadic logopenic aphasia and positive Alzheimer biomarkers who was subsequently found also to have a pathogenic mutation in the progranulin gene. This was signalled by early atypical features (mild expressive agrammatism and behavioural change, rapid clinical deterioration) around the core logopenic aphasia syndrome. Each of the canonical progressive aphasia syndromes has a ‘halo’ of less typical variants that may herald alternative or additional pathologies. The accurate diagnosis of primary progressive aphasia depends on careful clinical analysis to direct investigations appropriately.
- ALZHEIMER-S DISEASE
Data availability statement
Data are available upon reasonable request to the corresponding author.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Read the full text or download the PDF:
Other content recommended for you
- New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications
- Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review
- Frontotemporal dementia
- Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias
- Clinical comparison of progressive aphasia associated with Alzheimer versus FTD-spectrum pathology
- Speech and language therapy approaches to managing primary progressive aphasia
- Plasma tau is increased in frontotemporal dementia
- Logopenic aphasia in Alzheimer's disease: clinical variant or clinical feature?
- Biomarkers in dementia: clinical utility and new directions
- Remote versus face-to-face neuropsychological testing for dementia research: a comparative study in people with Alzheimer’s disease, frontotemporal dementia and healthy older individuals